OneChain Immunotherapeutics
Mª José Mansilla is a postdoctoral researcher currently working at OneChain Immunotherapeutics since April 2023, focusing on preclinical research for advanced cancer immunotherapies. From January 2013 to April 2023, Mª José held a postdoctoral position at the Instituto de Investigación en Ciencias de la Salud Germans Trias i Pujol. Prior to this, Mª José completed a PhD at VHIR Vall d’Hebron Institut de Recerca in 2012, specializing in the differentiation of induced pluripotent stem cells (iPS). Mª José's early research experience includes predoctoral positions at the Institut de Recerca - Hospital Universitari Vall d'Hebron, where investigations centered on the pathogenesis of Multiple Sclerosis using animal models between 2005 and 2011. Mª José obtained a degree in Biotechnology from Universitat Autònoma de Barcelona in 2005.
This person is not in any teams
OneChain Immunotherapeutics
OneChain Immunotherapeutics is a spin-off Company from Instituto de Investigación contra la Leucemia Josep Carreras and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez.